Mara Rosenberg

Active 2013–2019

30
Papers
24,296
Citations
29
h-index
30
i10-index

Citations

Citations per year for Mara Rosenberg1991: 1 citations1993: 1 citations1997: 1 citations2000: 1 citations2003: 1 citations2006: 2 citations2007: 2 citations2009: 1 citations2011: 1 citations2012: 1 citations2013: 8 citations2014: 159 citations2015: 371 citations2016: 435 citations2017: 539 citations2018: 546 citations2019: 1,431 citations2020: 1,629 citations2021: 1,457 citations2022: 1,081 citations2023: 751 citations2024: 1,054 citations2025: 487 citations2026: 24 citations1992: no citations, so this year is not shown1994–1996: no citations, so these years are not shown1998–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown2004–2005: no citations, so these years are not shown2008: no citations, so this year is not shown2010: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,741 citing papers, 28.9% of this breakdownChina: 1,770 citing papers, 10.8% of this breakdownUnited Kingdom: 1,014 citing papers, 6.2% of this breakdownGermany: 1,013 citing papers, 6.2% of this breakdownItaly: 798 citing papers, 4.9% of this breakdownFrance: 622 citing papers, 3.8% of this breakdownSpain: 588 citing papers, 3.6% of this breakdownCanada: 575 citing papers, 3.5% of this breakdownJapan: 555 citing papers, 3.4% of this breakdownAustralia: 416 citing papers, 2.5% of this breakdownSwitzerland: 405 citing papers, 2.5% of this breakdownNetherlands: 399 citing papers, 2.4% of this breakdown
0%28.9%Other 21.3%

Fields

  • Medicine53.3%
  • Biochemistry, Genetics and Molecular Biology41.4%
  • Immunology and Microbiology2.9%
  • Computer Science0.9%
  • Engineering0.4%
  • Chemistry0.2%
  • Other0.9%

Topics

  • Cancer Genomics and Diagnostics8.6%
  • Lung Cancer Treatments and Mutations4.6%
  • Cancer Immunotherapy and Biomarkers3.2%
  • Pancreatic and Hepatic Oncology Research2.8%
  • Lymphoma Diagnosis and Treatment2.8%
  • RNA modifications and cancer2.8%
  • Other75.2%

Coauthors

All papers

Open in search
  1. Comprehensive molecular profiling of lung adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rameen Beroukhim, Juok Cho, Daniel DiCara, David Heiman, Pei Lin, William Mallard, Douglas Voet, Hailei Zhang, Lihua Zou, Michael S. Noble, Nils Gehlenborg, Helga Thorvaldsdottir, Marc-Danie Nazaire, Jim Robinson, William Lee, Marc Ladanyi, Nikolaus Schultz, Ronglai Shen, William D. Travis, B. Arman Aksoy, Giovanni Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, Venkatraman E. Seshan, Boris Reva, Rileen Sinha, S. Onur Sumer, Nils Weinhold, Chris Sander, Natasha Rekhtman, Maureen Zakowski, Valerie W. Rusch, David G. Beer, Leslie Cope, Ludmila Danilova, James G. Herman, Stephen B. Baylin, Peter Illei, Edward Gabrielson, James Shin, Beverly Lee, Kristen Rodgers, Dante Trusty, Malcolm V. Brock, Chad J. Creighton, David Wheeler, Li Ding, Ramaswamy Govindan, Cyriac Kandoth, Robert Fulton, Lucinda L. Fulton, Michael D. McLellan, Richard K. Wilson, Kai Ye, Catrina C. Fronick, Christopher A. Maher, Christopher A. Miller, Michael C. Wendl, Christopher Cabanski, Elaine Mardis, Mark A. Watson, Sandra McDonald, Bryan Meyers, Raju Kucherlapati, Angela Hadjipanayis, Eran Hodis, Semin Lee, Angeliki Pantazi, Xiaojia Ren and 210 more - Nature 2014 cited by 5,918

  2. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric S. Lander, Bradley A. Murray, Julian M. Hess, Mara Rosenberg, Louis Bergelson, Hailei Zhang, Juok Cho, Grace Tiao, Jaegil Kim, Dimitri Livitz, Ignaty Leshchiner, Brendan Reardon, Eliezer M. Van Allen, Atanas Kamburov, Rameen Beroukhim, Gordon Saksena, Steven E. Schumacher, Michael S. Noble, David I. Heiman, Nils Gehlenborg, Jaegil Kim, Michael S. Lawrence, Volkan Adsay, Gloria M. Petersen, David S. Klimstra, Nabeel Bardeesy, Mark D.M. Leiserson, Reanne Bowlby, Katayoon Kasaian, İnanç Birol, Karen Mungall, Sara Sadeghi, John N. Weinstein, Paul T. Spellman, Yuexin Liu, Laufey T. Ámundadóttir, Joel E. Tepper, Aatur D. Singhi, Rajiv Dhir, Paul Drwiega, Thomas C. Smyrk, Lizhi Zhang, Paula Kim, Jay Bowen, Jessica Frick, Julie M. Gastier‐Foster, Mark Gerken, Kevin Lau, Kristen Leraas, Tara M. Lichtenberg, Nilsa C. Ramirez, Jeremy Renkel, Mark E. Sherman, Lisa Wise, Peggy Yena, Erik Zmuda, Juliann Shih, Adrian Ally, Miruna Balasundaram, Rebecca Carlsen, Andy Chu, Eric Chuah, Amanda Clarke, Noreen Dhalla, Robert A. Holt, Steven J.M. Jones, Darlene Lee, Yussanne Ma, Marco A. Marra, Michael Mayo and 171 more - Cancer Cell 2017 cited by 2,069

  3. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Reiner Siebert, Andreas Rosenwald, Aaron R. Thorner, Matthew Meyerson, Todd R. Golub, Rameen Beroukhim, Gerald Wulf, German Ott, Scott J. Rodig, Stefano Monti, Donna Neuberg, Markus Loeffler, Michael Pfreundschuh, Lorenz Trümper, Gad Getz, Margaret A. Shipp - Nature Medicine 2018 cited by 1,972

  4. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Leeson, Rachel Barry, Joseph F. Kramkowski, Zhenwei Zhang, L Polácek, Jens G. Lohr, Molly Schleicher, Emily Lipscomb, Andrea Saltzman, Nelly Oliver, Lori Marini, Adrienne G. Waks, Lauren C. Harshman, Sara M. Tolaney, Eliezer M. Van Allen, Eric P. Winer, Nancy U. Lin, Mari Nakabayashi, Mary‐Ellen Taplin, Cory M. Johannessen, Levi A. Garraway, Todd R. Golub, Jesse S. Boehm, Nikhil Wagle, Gad Getz, J. Christopher Love, Matthew Meyerson - Nature Communications 2017 cited by 1,095

  5. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 cited by 1,234

  6. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Rabin, Nancy U. Lin, Eric P. Winer, Anat Stemmer‐Rachamimov, Matthew Meyerson, Levi A. Garraway, Stacey Gabriel, Eric S. Lander, Rameen Beroukhim, Tracy T. Batchelor, José Baselga, David N. Louis, Gad Getz, William C. Hahn - Cancer Discovery 2015 cited by 1,136

  7. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2016 cited by 930

  8. The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

    Authors: , , , , , , , , , , , , , , , - Cancer Discovery 2019 cited by 366

  9. Mutations driving CLL and their evolution in progression and relapse

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine J. Wu - Nature 2015 cited by 1,078

  10. Landscape of genomic alterations in cervical carcinomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mari K. Halle, Erling A. Høivik, Camilla Krakstad, Nayeli Belem Gabiño, Gabriela Sofía Gómez-Macias, Lezmes Dionicio Valdez-Chapa, María Lourdes Garza-Rodríguez, German Maytorena, Jorge Vazquez, Carlos Rodea, Adrian Cravioto, Maria L. Cortés, Heidi Greulich, Christopher P. Crum, Donna Neuberg, Alfredo Hidalgo‐Miranda, Claudia Rangel‐Escareño, Lars A. Akslen, Thomas E. Carey, Olav Karsten Vintermyr, Stacey Gabriel, Hugo A. Barrera‐Saldaña, Jorge Meléndez-Zajgla, Gad Getz, Helga B. Salvesen, Matthew Meyerson - Nature 2013 cited by 891

  11. Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. Vincent Rajkumar, Shaji Kumar, Rafaël Fonseca, Greg Ahmann, P. Leif Bergsagel, A. Keith Stewart, Craig C. Hofmeister, Yvonne A. Efebera, Sundar Jagannath, Ajai Chari, Suzanne Trudel, Donna Reece, Jeffrey Wolf, Thomas Martin, Todd M. Zimmerman, Cara A. Rosenbaum, Andrzej Jakubowiak, Daniel Lebovic, Ravi Vij, Keith Stockerl-Goldstein - Cancer Cell 2014 cited by 1,004

  12. Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2014 cited by 777

  13. The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Levi A. Garraway, Dirk Schadendorf - Cancer Discovery 2013 cited by 940

  14. The Genomic Landscape of Pediatric Ewing Sarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Todd R. Golub, Gad Getz, Jaume Mora, Kimberly Stegmaier - Cancer Discovery 2014 cited by 589

  15. MAP Kinase Pathway Alterations in BRAF -Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 473

  16. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aviv Regev, Matthew Meyerson, William C. Hahn, Philip W. Kantoff, Todd R. Golub, Gad Getz, Jesse S. Boehm, J. Christopher Love - Nature Biotechnology 2014 cited by 534

  17. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barrett J. Rollins, Philip W. Kantoff, Sheila Fisher, Stacey Gabriel, Gad Getz, Levi A. Garraway - Nature Medicine 2014 cited by 571

  18. DeTiN: overcoming tumor-in-normal contamination

    Authors: , , , , , , , , , , - Nature Methods 2018 cited by 110

  19. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

    Authors: , , , , , , , , , , , , , , , , - Blood 2018 cited by 108

  20. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

    Authors: , , , , , , , , , , - Nature Genetics 2013 cited by 594

  21. Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 326

  22. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 cited by 205

  23. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaegil Kim, Juliann Shih, Gordon Saksena, Andrew D. Cherniack, Steven E. Schumacher, Amaro-Taylor Weiner, Mara Rosenberg, Gad Getz, Eun Gyeong Yang, Min‐Hee Ryu, Adam J. Bass, Hark Kyun Kim - Gastroenterology 2017 cited by 180

  24. Recurrent and functional regulatory mutations in breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , André Bernards, Eric S. Lander, Gad Getz - Nature 2017 cited by 319